Dieses Ratte Monoklonal-Antikörper erkennt spezifisch RAGE in WB, IF und IHC (fro). Er zeigt eine Reaktivität gegenüber Maus und wurde in 1 Publikation erwähnt.
Mouse Recombinant RAGE extracellular domain. Remarks: This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from an immunized rat).
AGER
Reaktivität: Human
WB, IF
Wirt: Kaninchen
Polyclonal
RB21217
unconjugated
Applikationshinweise
Western Blot: 1/500-1/1000. Immunohistochemistry on Frozen Sections: 1/50-1/100. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Rekonstitution
Restore with 200 μL sterile PBS and the final concentration is 500 μg/mL.
Konzentration
0,5 mg/mL
Buffer
PBS without preservatives
Konservierungsmittel
Without preservative
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Prior to reconstitution store at 2-8 °C. Following reconstitution store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
RAGE (AGER)
(Advanced Glycosylation End Product-Specific Receptor (AGER))
Andere Bezeichnung
RAGE / AGER
Hintergrund
The Receptor for Advanced Glycation Endproducts (RAGE) is a member of the Immunoglobin superfamily of cell surface markers. This protein is able to interact with many molecules including: advanced glycation endproducts (AGE), amphoterin, and ligands. Research has shown that the accumulation of RAGE ligands in the biological system (endothelium mononuclear phagocytes, neurons and smooth muscle cells) can lead to destructive tissue diseases such as diabetic retinopathy, amyloidoses, tumors and inflammation disorders. RAGE is expressed by endothelium mononuclear phagocytes, smooth muscle and neurons.Synonyms: Advanced glycosylation end product-specific receptor, Receptor for advanced glycosylation end products